companydata.dkInVitroLogics ApS: Financial statements 2024
CVR: 34044562
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,326 and a net result of DKK -1,327 compared with DKK -15,211 the year before. Equity amounted to DKK -330,513.
- Gross Profit
- -1,326 kr.
- Profit/Loss
- -1,327 kr.
- Equity
- -330,513 kr.
- Total Assets
- 10,984 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1 t. | -1 t. | -331 t. | - |
| 2023 | - | -15 t. | -15 t. | -411 t. | - |
| 2022 | - | -64 t. | -76 t. | -395 t. | 0 |
| 2021 | 48 t. | 48 t. | 37 t. | -319 t. | - |
| 2020 | - | -41 t. | -41 t. | -356 t. | - |
How creditworthy is InVitroLogics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
InVitroLogics ApS has published its annual report for 2023. Gross profit came to DKK -15,211, and the net result was DKK -15,211.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity amounted to DKK -333,763.